Repligen Corporation (RGEN)
- Exchange
- NASDAQ
- Symbol
- RGEN
- Sector
- Life Sciences
- Industry
- Biological Products, (no Disgnostic Substances)
- Description
- Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally. The company is headquartered in Waltham, Massachusetts.
- Country
- USA
Stock price
At close: November 20, 2024
-
Open129.58
-
High139.20
-
Low128.53
-
Close138.90
-
Volume818,398
Financial ratios
Dec 31, 2023
Activity ratios
Liquidity ratios
Solvency ratios
Profitability ratios
Inventory turnover
2.93
Receivables turnover
5.03
Payables turnover
30.33
Working capital turnover
0.66
Days of inventory on hand (DOH)
124.44
Days of sales outstanding (DSO)
72.61
Number of days of payables
12.03
Fixed asset turnover
3.01
Total asset turnover
0.22
Current ratio
7.02
Quick ratio
5.54
Cash ratio
4.75
Cash conversion cycle
185.02
Debt-to-assets ratio
0.18
Debt-to-capital ratio
0.21
Debt-to-equity ratio
0.26
Financial leverage ratio
1.43
Interest coverage
33.89
Gross profit margin
4.92%
Operating profit margin
8.74%
Pretax margin
10.28%
Net profit margin
6.66%
Operating return on assets (Operating ROA)
1.93%
Return on assets (ROA)
1.47%
Return on total capital
2.66%
Return on equity (ROE)
2.11%